Nonmuscle invasive transitional cell carcinoma of urinary bladder – adjuvant intravesical therapies after transurethral tumor resection

HIGHLIGHTS

  • who: PROBLEME DE CERCETARE and collaborators from the Faculty of Medicine, Lucian Blaga University, Sibiu have published the paper: NONMUSCLE INVASIVE TRANSITIONAL CELL CARCINOMA OF URINARY BLADDER - ADJUVANT INTRAVESICAL THERAPIES AFTER TRANSURETHRAL TUMOR RESECTION, in the Journal: (JOURNAL)
  • what: The aim of this study is to compare the efficacity and safety of intravesical immunotherapy with Bacillus Calmette Guerin (BCG) vs. chemotherapy (Pharmoribicin) after TUR-B for NMIBC. The aim of the diagnosis is to establish the clinical and histopathological stage for differentiate beetwen nonmuscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC). The . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?